Ouro Medicines logo

Ouro Medicines Funding & Investors

San Francisco, CA

Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline.

ouromedicines.com

Total Amount Raised: $120,000,000

Ouro Medicines Funding Rounds

  • Series A

    $120,000,000

    Series A Investors

    New Enterprise Associates (NEA)
    Norwest Venture Partners
    TPG
    GSK
    LongRiver Investments
    UPMC
    Monograph Capital
    Boyu Capital
Funding info provided by Diffbot.